Home  /  Resource Library  /  Rituximab Extended Schedule or Re-Treatment Trial for Low-Tumor Burden Follicular Lymphoma: Eastern Cooperative Oncology Group Protocol E4402

Rituximab Extended Schedule or Re-Treatment Trial for Low-Tumor Burden Follicular Lymphoma: Eastern Cooperative Oncology Group Protocol E4402

In patients with low-tumor burden follicular lymphoma, a retreatment strategy using rituximab provides comparable disease control with that achieved by rituximab maintenance strategy.